Empyema in a patient treated with infliximab: it is not what it seems
Reduced IgG levels can be the result of long term prednisone treatment or chronic infection. 1 Isolated IgG2 subclass deficiency may result in enhanced susceptibility to encapsulated bacteria. 2 Another report suggests an increased susceptibility to invasive pneumococcal disease in homozygotes for M...
Gespeichert in:
| Veröffentlicht in: | Annals of the rheumatic diseases 2005-11, Vol.64 (11), p.1657-1658 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1658 |
|---|---|
| container_issue | 11 |
| container_start_page | 1657 |
| container_title | Annals of the rheumatic diseases |
| container_volume | 64 |
| creator | Bossink, A Thijsen, S van Houte, A J |
| description | Reduced IgG levels can be the result of long term prednisone treatment or chronic infection. 1 Isolated IgG2 subclass deficiency may result in enhanced susceptibility to encapsulated bacteria. 2 Another report suggests an increased susceptibility to invasive pneumococcal disease in homozygotes for MBL codon variants. 3 It is tempting to speculate that the immunomodulating effect of infliximab contributed to the two episodes of thoracic empyema. |
| doi_str_mv | 10.1136/ard.2004.034959 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1755261</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008365821</sourcerecordid><originalsourceid>FETCH-LOGICAL-b415t-98338d88784019de894ff6bb3bfdca56c249d6ba2dc5692a88d485bbca8d0be33</originalsourceid><addsrcrecordid>eNqFkEtrGzEUhUVoSdw06-yKoLvAOHqNHl0UguMkheBQaLvoRkgjTS3XM-NIcpP8-8iMSdtVVpfL-e65hwPAKUZTjCk_N9FNCUJsiihTtToAE8y4rAji6A2YIIRoxRQXR-BdSquyIonlITjCnBDBCJqA-bzbPPnOwNBDAzcmB99nmKM32Tv4EPKyKO06PIbO2E8wZBgS7IcMH5Ym79bkfZfeg7etWSd_sp_H4PvV_Nvsprq9u_4yu7itLMN1rpSkVDophWQIK-elYm3LraW2dY2peUOYctwa4pqaK2KkdEzW1jZGOmQ9pcfg8-i72drOu6ZkjWatN7Gki096MEH_r_RhqX8NfzQWdU04LgYf9wZxuN_6lPVq2Ma-ZC6IEEowTFihzkeqiUNK0bcvHzDSu9516V3vetdj7-Xiw7_B_vL7ogtQjUBI2T--6Cb-1lxQUevFj5m-vPwprhaLr_q68Gcjb7vVq9-fAbD-mxc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777974124</pqid></control><display><type>article</type><title>Empyema in a patient treated with infliximab: it is not what it seems</title><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ）</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Bossink, A ; Thijsen, S ; van Houte, A J</creator><creatorcontrib>Bossink, A ; Thijsen, S ; van Houte, A J</creatorcontrib><description>Reduced IgG levels can be the result of long term prednisone treatment or chronic infection. 1 Isolated IgG2 subclass deficiency may result in enhanced susceptibility to encapsulated bacteria. 2 Another report suggests an increased susceptibility to invasive pneumococcal disease in homozygotes for MBL codon variants. 3 It is tempting to speculate that the immunomodulating effect of infliximab contributed to the two episodes of thoracic empyema.</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/ard.2004.034959</identifier><identifier>PMID: 16227420</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><subject>Aged ; Antibodies, Monoclonal - adverse effects ; Antirheumatic Agents - adverse effects ; Bacteria ; empyema ; Empyema, Pleural - etiology ; Female ; Humans ; IgG Deficiency - complications ; Infections ; Infliximab ; Letter ; Opportunistic Infections - etiology ; Pneumonia</subject><ispartof>Annals of the rheumatic diseases, 2005-11, Vol.64 (11), p.1657-1658</ispartof><rights>Copyright 2005 by Annals of the Rheumatic Diseases</rights><rights>Copyright: 2005 Copyright 2005 by Annals of the Rheumatic Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b415t-98338d88784019de894ff6bb3bfdca56c249d6ba2dc5692a88d485bbca8d0be33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755261/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755261/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16227420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bossink, A</creatorcontrib><creatorcontrib>Thijsen, S</creatorcontrib><creatorcontrib>van Houte, A J</creatorcontrib><title>Empyema in a patient treated with infliximab: it is not what it seems</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Reduced IgG levels can be the result of long term prednisone treatment or chronic infection. 1 Isolated IgG2 subclass deficiency may result in enhanced susceptibility to encapsulated bacteria. 2 Another report suggests an increased susceptibility to invasive pneumococcal disease in homozygotes for MBL codon variants. 3 It is tempting to speculate that the immunomodulating effect of infliximab contributed to the two episodes of thoracic empyema.</description><subject>Aged</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antirheumatic Agents - adverse effects</subject><subject>Bacteria</subject><subject>empyema</subject><subject>Empyema, Pleural - etiology</subject><subject>Female</subject><subject>Humans</subject><subject>IgG Deficiency - complications</subject><subject>Infections</subject><subject>Infliximab</subject><subject>Letter</subject><subject>Opportunistic Infections - etiology</subject><subject>Pneumonia</subject><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkEtrGzEUhUVoSdw06-yKoLvAOHqNHl0UguMkheBQaLvoRkgjTS3XM-NIcpP8-8iMSdtVVpfL-e65hwPAKUZTjCk_N9FNCUJsiihTtToAE8y4rAji6A2YIIRoxRQXR-BdSquyIonlITjCnBDBCJqA-bzbPPnOwNBDAzcmB99nmKM32Tv4EPKyKO06PIbO2E8wZBgS7IcMH5Ym79bkfZfeg7etWSd_sp_H4PvV_Nvsprq9u_4yu7itLMN1rpSkVDophWQIK-elYm3LraW2dY2peUOYctwa4pqaK2KkdEzW1jZGOmQ9pcfg8-i72drOu6ZkjWatN7Gki096MEH_r_RhqX8NfzQWdU04LgYf9wZxuN_6lPVq2Ma-ZC6IEEowTFihzkeqiUNK0bcvHzDSu9516V3vetdj7-Xiw7_B_vL7ogtQjUBI2T--6Cb-1lxQUevFj5m-vPwprhaLr_q68Gcjb7vVq9-fAbD-mxc</recordid><startdate>200511</startdate><enddate>200511</enddate><creator>Bossink, A</creator><creator>Thijsen, S</creator><creator>van Houte, A J</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>Elsevier Limited</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>200511</creationdate><title>Empyema in a patient treated with infliximab: it is not what it seems</title><author>Bossink, A ; Thijsen, S ; van Houte, A J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b415t-98338d88784019de894ff6bb3bfdca56c249d6ba2dc5692a88d485bbca8d0be33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aged</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antirheumatic Agents - adverse effects</topic><topic>Bacteria</topic><topic>empyema</topic><topic>Empyema, Pleural - etiology</topic><topic>Female</topic><topic>Humans</topic><topic>IgG Deficiency - complications</topic><topic>Infections</topic><topic>Infliximab</topic><topic>Letter</topic><topic>Opportunistic Infections - etiology</topic><topic>Pneumonia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bossink, A</creatorcontrib><creatorcontrib>Thijsen, S</creatorcontrib><creatorcontrib>van Houte, A J</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bossink, A</au><au>Thijsen, S</au><au>van Houte, A J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Empyema in a patient treated with infliximab: it is not what it seems</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2005-11</date><risdate>2005</risdate><volume>64</volume><issue>11</issue><spage>1657</spage><epage>1658</epage><pages>1657-1658</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Reduced IgG levels can be the result of long term prednisone treatment or chronic infection. 1 Isolated IgG2 subclass deficiency may result in enhanced susceptibility to encapsulated bacteria. 2 Another report suggests an increased susceptibility to invasive pneumococcal disease in homozygotes for MBL codon variants. 3 It is tempting to speculate that the immunomodulating effect of infliximab contributed to the two episodes of thoracic empyema.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><pmid>16227420</pmid><doi>10.1136/ard.2004.034959</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0003-4967 |
| ispartof | Annals of the rheumatic diseases, 2005-11, Vol.64 (11), p.1657-1658 |
| issn | 0003-4967 1468-2060 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1755261 |
| source | MEDLINE; Free E-Journal (出版社公開部分のみ）; PubMed Central; Alma/SFX Local Collection |
| subjects | Aged Antibodies, Monoclonal - adverse effects Antirheumatic Agents - adverse effects Bacteria empyema Empyema, Pleural - etiology Female Humans IgG Deficiency - complications Infections Infliximab Letter Opportunistic Infections - etiology Pneumonia |
| title | Empyema in a patient treated with infliximab: it is not what it seems |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T14%3A50%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Empyema%20in%20a%20patient%20treated%20with%20infliximab:%20it%20is%20not%20what%20it%20seems&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Bossink,%20A&rft.date=2005-11&rft.volume=64&rft.issue=11&rft.spage=1657&rft.epage=1658&rft.pages=1657-1658&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/ard.2004.034959&rft_dat=%3Cproquest_pubme%3E4008365821%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777974124&rft_id=info:pmid/16227420&rfr_iscdi=true |